Ferric Carboxymaltose in HF with Iron Deficiency | NEJM
17
0
2024-1-5 16:36
Semaglutide in Heart Failure with Obesity | NEJM
心電図がない時のＤＣＭ
Dennis’ Patient Story - Living with HeartMate 3 LVAD for Heart Failure
Is the Price Right? Heart Failure Drug Choices
Upping the Pace in Acute Decompensated Heart Failure Therapy
Integrated Heart Failure Patient Management EP and HF Perspective
Heart Failure Guidelines Update What the ESC Got Right
Managing Heart Failure - Creating a Plan for Testing, Medication and Nutrition
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
In patients with heart failure, a reduced ejection fraction, and iron deficiency, intravenous ferric carboxymaltose improves quality of life and functional capacity; clinical outcomes are unclear.
New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/44rzIe4
Comments 0
Please to post a comment~
Loading...
Related Suggestion